Korea’s vaccine contract volume is the 14th in the world, but vaccination is ‘0’ …78 countries have already started vaccination

Kazuhiro Araki (新木一弘, left), Tokyo Medical Center Director, is receiving the first Corona 19 vaccine in Japan at the Tokyo Medical Center on the 17th. Tokyo/AP=Newsis

It was found that 78 countries have started vaccination against the novel coronavirus infection (Corona 19). Korea was not here. It is not far behind the 14th place in the world in terms of the amount of COVID-19 vaccine secured, but it is because the actual vaccine was not supplied only with a contract. It is a painful mistake in our quarantine. Because of this, there are high voices that the rate of vaccination starting on the 26th should be greatly increased.

According to Bloomberg News on the 17th (local time), about 181 million doses (1 dose = 1 dose) of the Corona 19 vaccine have been inoculated in 78 countries so far. Looking at 78 countries, not only major developed countries, but also a number of developing countries, including Bangladesh, Sri Lanka, Myanmar, Malta and Bolivia, have already begun vaccination.

Based on this, Bloomberg estimates that an average of about 6.41 million doses are being inoculated worldwide every day. Korea, the world’s tenth-largest economy, failed to join this rank. As vaccine contracts are delayed compared to other countries, the order of product supply seems to have been pushed back.

Bloomberg is providing information on the’Corona 19 Tracker’ website so that you can see at a glance the figures related to the COVID-19 vaccine contract and the vaccinated population released through official announcements, press conferences, public messages, and interviews by governments. .

According to this data, India (2.2 billion doses), which is called “the world’s pharmacy,” is the country with the most corona19 vaccine. As there are many pharmaceutical production facilities, it is estimated that there was an advantage in securing vaccines. The European Union (EU, 1.48 billion doses) and the United States (1.210 billion doses) followed.

Korea ranked 16th with 84 million doses. Considering that the NovaVax vaccine, which was recently signed for 20 million people, has not yet been reflected in the Bloomberg tracker, the actual amount secured by Korea jumps to 152 million doses, so the ranking rises to about 14th. It is lower than Indonesia (31 million dos), China (300 million dos), Japan (290 million dos), Brazil (246 million dos), Mexico (211 million dos), but is around 10th. It is difficult to say that there is a shortage of securing the volume itself.

The amount of COVID-19 vaccine secured by country. Source: Bloomberg

Percentage of population who received two doses of the COVID-19 vaccine by country. Source: Bloomberg

The problem is that the vaccination has not even started. All of the vaccines over 100 million doses exist only under contract documents. At a New Year’s press conference held last month, President Moon Jae-in’s comment that the Corona 19 vaccine is being introduced “sufficiently and quickly” is far from reality. While we belatedly and urgently secured supplies, Israel already had 29.7% of the population vaccinated against Corona 19 twice. 45% of the population who received a single vaccination is already close to half. 14.8% of the Seychelles and 4.7% of the U.S. completed 2 doses. European countries, such as Italy, Spain, and Romania, also received two doses of over 2% of the population.

Experts stress that now that we have secured a vaccine that is 1.5 times the population, we must focus on speeding up vaccination. Bloomberg predicts that at the current rate, it will take 4.9 years for 75% of the world’s population to get vaccinated twice. It was less than the 7-year forecast earlier this month, but it is still slow. Tom Frieden, former director of the Centers for Disease Control and Prevention (CDC), urged that “in the future, vaccination takes time.”

Lim So-hyung reporter




Subscribe to the Hankook Ilbo News Naver Channel
Subscribe on Newsstand

Balance to see the world, the Hankook Ilbo Copyright © Hankookilbo

Issues you may be interested in

.Source